Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions. STANDARD EXCLUSIVE LICENSE...Standard Exclusive License Agreement • January 22nd, 2021 • Decibel Therapeutics, Inc. • Pharmaceutical preparations • Florida
Contract Type FiledJanuary 22nd, 2021 Company Industry JurisdictionThis Agreement is effective as of the last signature on this agreement, (the “Effective Date”) between the University of Florida Research Foundation, Incorporated, a nonstock, nonprofit Florida corporation (“UFRF”), and Decibel Therapeutics, Inc., a Corporation organized under the laws of the state of Delaware (“Licensee”).
Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions. STANDARD EXCLUSIVE LICENSE...Standard Exclusive License Agreement • December 11th, 2020 • Decibel Therapeutics, Inc. • Pharmaceutical preparations • Florida
Contract Type FiledDecember 11th, 2020 Company Industry JurisdictionThis Agreement is effective as of the last signature on this agreement, (the “Effective Date”) between the University of Florida Research Foundation, Incorporated, a nonstock, nonprofit Florida corporation (“UFRF”), and Decibel Therapeutics, Inc., a Corporation organized under the laws of the state of Delaware (“Licensee”).